2012
DOI: 10.2146/ajhp120096
|View full text |Cite
|
Sign up to set email alerts
|

Subcutaneous heparin for treatment of hypertriglyceridemia-induced pancreatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…Initial treatment of HTIP includes pancreas rest (by limiting oral intake, aggressive intravenous hydration, and analgesia) [ 5 ]. For further treatment of HTIP, plasmapheresis [ 7 9 ], heparin infusion [ 10 16 ], and subcutaneous heparin [ 17 ] were reported, but still they are considered as experimental treatment modalities in HTIP [ 5 ]. Apheresis has been recommended as category III (optimum role of apheresis therapy is not established; individualized decision is necessary) and grade-2C (weak recommendation, low-quality, or very low-quality evidence) for hypertriglyceridemic pancreatitis by American Society for Apheresis [ 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…Initial treatment of HTIP includes pancreas rest (by limiting oral intake, aggressive intravenous hydration, and analgesia) [ 5 ]. For further treatment of HTIP, plasmapheresis [ 7 9 ], heparin infusion [ 10 16 ], and subcutaneous heparin [ 17 ] were reported, but still they are considered as experimental treatment modalities in HTIP [ 5 ]. Apheresis has been recommended as category III (optimum role of apheresis therapy is not established; individualized decision is necessary) and grade-2C (weak recommendation, low-quality, or very low-quality evidence) for hypertriglyceridemic pancreatitis by American Society for Apheresis [ 18 ].…”
Section: Discussionmentioning
confidence: 99%